Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sack

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 10, 2021
Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonistsZheming Ruan, Peter K Park, Donna Wei, et al.
Annals of the American Thoracic Society|December 1, 2020
Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop ReportKerri A Johannson, Hayley Barnes, Anne-Pauline Bellanger, et al.
Physical Review Letters|July 13, 2004
Photoproduction of eta-mesic 3HeM Pfeiffer, J Ahrens, J R M Annand, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonistsLalgudi S Harikrishnan, Patrice Gill, Muthoni G Kamau, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse AgonistsJames J-W Duan, Zhonghui Lu, Bin Jiang, et al.
Journal of Medicinal Chemistry|August 12, 2008
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activitiesKyoung Soon Kim, Liping Zhang, Robert Schmidt, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2017
Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitorsJohn Hynes, Hong Wu, James Kempson, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2011
Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3Lalgudi S Harikrishnan, Muthoni G Kamau, Honghe Wan, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid ArthritisSteven H Spergel, Michael E Mertzman, James Kempson, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry Letters|January 10, 2021
Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonistsZheming Ruan, Peter K Park, Donna Wei, et al.
Annals of the American Thoracic Society|December 1, 2020
Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop ReportKerri A Johannson, Hayley Barnes, Anne-Pauline Bellanger, et al.
Physical Review Letters|July 13, 2004
Photoproduction of eta-mesic 3HeM Pfeiffer, J Ahrens, J R M Annand, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonistsLalgudi S Harikrishnan, Patrice Gill, Muthoni G Kamau, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse AgonistsJames J-W Duan, Zhonghui Lu, Bin Jiang, et al.
Journal of Medicinal Chemistry|August 12, 2008
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activitiesKyoung Soon Kim, Liping Zhang, Robert Schmidt, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2017
Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitorsJohn Hynes, Hong Wu, James Kempson, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2011
Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3Lalgudi S Harikrishnan, Muthoni G Kamau, Honghe Wan, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid ArthritisSteven H Spergel, Michael E Mertzman, James Kempson, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Pageof 25